Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study-Reference-Cited by-同舟云学术

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study

Published:2023-01 Issue: Volume:24 Page:100542
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Wilson Sarah^ORCID,Calocer Floriane,Rollot Fabien,Fauvernier Mathieu,Remontet Laurent,Tron Laure,Vukusic Sandra,Le Page Emmanuelle,Debouverie Marc,Ciron Jonathan^ORCID,Ruet Aurélie,De Sèze Jérôme,Zephir Hélène,Moreau Thibault,Lebrun-Frénay Christine,Laplaud David-Axel,Clavelou Pierre,Labauge Pierre,Berger Eric,Pelletier Jean,Heinzlef Olivier,Thouvenot Eric,Camdessanché Jean Philippe,Leray Emmanuelle,Dejardin Olivier,Defer Gilles

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference46 articles.

1. Diagnosis and treatment of multiple sclerosis: a review;McGinley;JAMA,2021

2. Effect of comorbidity on mortality in multiple sclerosis;Marrie;Neurology,2015

3. Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: data from a large-scale French observational study;Leray;PLoS One,2015

4. Effects of age and disease duration on excess mortality in patients with multiple sclerosis from a French nationwide cohort;Rollot;Neurology,2021

5. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada;Kingwell;J Neurol Neurosurg Psychiatry,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040;Frontiers in Medicine;2024-08-22

2. Association of Neighborhood Socioeconomic Status With Withdrawal of Life-Sustaining Therapies After Intracerebral Hemorrhage;Neurology;2024-02-13

3. MS care: integrating advanced therapies and holistic management;Frontiers in Neurology;2024-01-30

4. The effect of disease modifying therapies on fatigue in multiple sclerosis;Multiple Sclerosis and Related Disorders;2023-11

5. Socioeconomic, health-care access and clinical determinants of disease severity in Multiple Sclerosis in Chile;Multiple Sclerosis and Related Disorders;2023-10